secwatch.observer — SEC 8-K summary
======================================

Issuer:     RECURSION PHARMACEUTICALS, INC. (RXRX)
CIK:        0001601830
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0001601830-25-000088
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Recursion Pharmaceuticals stockholders elect directors, approve exec comp, ratify auditor at 2025 meeting
--------------------------------------------------------------------------------

- Elected Zachary Bogue (242.3M for, 4.0M withheld), Zavain Dar (203.3M for, 42.9M withheld), Robert Hershberg (233.5M for, 12.8M withheld) as Class I directors.
- Advisory resolution to approve executive compensation approved with 239.9M for, 3.2M against, 3.1M abstain, 93.4M broker non-votes.
- Ratification of PwC as independent auditor for FY2025 approved with 334.6M for, 2.0M against, 3.1M abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601830/000160183025000088/0001601830-25-000088-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601830/000160183025000088/rxrx-20250618.htm
  HTML page:      https://secwatch.observer/filing/0001601830-25-000088

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer